Basit öğe kaydını göster

dc.contributor.authorYazici M.
dc.contributor.authorAksakal E.
dc.contributor.authorDemircan S.
dc.contributor.authorŞahin M.
dc.contributor.authorSağkan O.
dc.date.accessioned2020-06-21T09:23:39Z
dc.date.available2020-06-21T09:23:39Z
dc.date.issued2005
dc.identifier.issn1302-8723
dc.identifier.urihttps://hdl.handle.net/20.500.12712/3624
dc.descriptionPubMed: 15755693en_US
dc.description.abstractObjective: To investigate the pathogenesis of coronary slow flow (CSF), C-reactive protein (CRP) levels as indicator of inflammation and procoagulant activity were studied in patients with CSF. Methods: Fifty-one patients (22 female, mean age; 53±10 years) who were admitted to our clinic with chest pain and had the diagnosis of CSF established by TIMI frame count method and coronary angiography, and 44 healthy subjects (18 female, mean age; 54±6 years) with normal coronary flow (NCF) were included in the study. Subjects with any infectious and systemic immune disease were excluded from the study. The CRP levels were measured from venous blood samples during admission, at 24th hour and after 3 months in all subjects. Additionally; fibrinogen, plasminogen, plasminogen activator inhibitor (PAI-1), tissue plasminogen activator (t-PA) and von Willebrand factor (vWF) levels were measured to determine the procoagulant activity. Results: There was no significant difference between CRP levels of patients with CSF and healthy subjects during admission (7.26±4.2 ng/dl vs. 6.43±2.8 ng/dl, p>0.05), at 24th hour (7.84±1.3 ng/dl vs. 6.32±2.5 ng/dl, p>0.05) and after 3 months (6.37±2.4 ng/dl vs. 6.18±3.3 ng/dl, p>0.05). There were no differences between levels of CRP when compared according to the TIMI frame count, number of vessels with CSF and artery in which CSF was dominant. Additionally; procoagulant activity assessed by fibrinogen, plasminogen, PAI-1, t-PA and vWF levels was similar in both groups. Conclusion: Our findings on normal levels of CRP and procoagulant activity, and lack of relation with TIMI frame count made us to think that inflammatory and procoagulant activity did not play a role in the pathogenesis of CSF.en_US
dc.language.isoturen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectC-reactive proteinen_US
dc.subjectCoronary slow flowen_US
dc.subjectInflammationen_US
dc.subjectProcoagulant activityen_US
dc.titleIs slow coronary flow related with inflammation and procoagulant stateen_US
dc.title.alternativeKoroner yavaş akim inflamasyonla ve prokoagülan durumla ilişkili midir?en_US
dc.typearticleen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume5en_US
dc.identifier.issue1en_US
dc.identifier.startpage3en_US
dc.identifier.endpage7en_US
dc.relation.journalAnadolu Kardiyoloji Dergisien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster